Investors should focus on the adjusted net income of $17.5 million as a better indicator of ongoing profitability. The one-time tax benefit is not repeatable, so future quarters will likely show lower net income unless operational performance improves. Monitor future guidance for any changes in revenue or expense outlook.
How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Feb 27 $145.26entry
- T+1 · 9mo ago +1.20%α +1.14% · $147.00
- T+5 · 9mo ago −10.77%α −8.79% · $129.61
- T+20 · 8mo ago −31.81%α −24.26% · $99.05
- T+60 · 6mo ago −51.49%α −60.88% · $70.46
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
TransMedics provided additional details on its Q4 2025 financial results, clarifying that the previously reported $105.4 million net income included a one-time $83.8 million tax benefit from releasing a $103.3 million U.S. valuation allowance. Adjusted net income for the quarter was $17.5 million. The company reaffirmed its expectation of future tax provisions aligning with statutory rates.
Key Financial Metrics
Key Facts
- TransMedics released a $103.3 million U.S. tax valuation allowance in Q4 2025, resulting in an $83.8 million net income tax benefit.
- Reported Q4 2025 net income was $105.4 million; adjusted net income, excluding the tax benefit, was $17.5 million.
- The annual effective tax rate for 2025 was (77.0)%, but would have been 19.1% without the valuation allowance release.
- The company expects future quarterly tax provisions to be in line with U.S. statutory corporate income tax rates.
Financial Impact
The one-time tax benefit of $83.8 million inflated Q4 net income by $87.9 million compared to adjusted figures. The core business generated $17.5 million in net income.
Risk Factors
- The significant one-time tax benefit may lead to unrealistic expectations for future profitability.
- The company has a material weakness in internal control over financial reporting, which could affect future financial statements.
- Future financial performance is subject to risks including market acceptance of the OCS, regulatory developments, and ability to sustain profitability.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-079392 |
| Document: d80286dex991.htm | 0001193125-26-079392 |
| Document: 0001193125-26-079392-index-headers.html | 0001193125-26-079392 |
| Document: 0001193125-26-079392-index.html | 0001193125-26-079392 |
| Document: 0001193125-26-079392.txt | 0001193125-26-079392 |
| CONTEXT: Previous Earnings (2026-02-24) | 0001193125-26-066953 |
Track record
9 reports on TMDX
3 of 4 bullish or bearish reports moved the stock their way by T+5. Best: +22.27% at T+60 after the Jun 11, 2026 report. 4 of 4 went positive at some point.
Filters
- Nov 9, 20267d ago 144 Neutral 2/10 Entry $90.95 Now $92.21 +1.39% settles Nov 17
- Nov 5, 202611d ago 8-K Bullish 6/10 Entry $88.24 to $91.38 Now $92.21 +4.50% ▲ +3.56% +0.96% vs SPY
- Nov 5, 202611d ago Press Release Bullish 6/10 No price data
- Jun 12, 202622w ago Institutional Cluster Bullish 6/10 Entry $72.91 to $78.79 Now $92.21 +26.47% ▲ +8.06% +7.39% vs SPY
- Jun 11, 202622w ago Institutional Cluster Bullish 5/10 Entry $73.59 to $73.22 Now $92.21 +25.30% ▼ −0.50% −0.94% vs SPY
- Apr 10, 202631w ago DEFA14A Neutral 3/10 Entry $114.00 to $115.87 Now $92.21 −19.11% ▲ +1.64% −2.86% vs SPY
- Mar 2, 202637w ago Insider Cluster Neutral 3/10 Entry $147.00 to $134.77 Now $92.21 −37.27% ▼ −8.32% −7.11% vs SPY
- Feb 27, 202637w ago 8-K Neutral 4/10 Viewing Entry $145.26 to $129.61 Now $92.21 −36.52% ▼ −10.77% −8.79% vs SPY
- Feb 24, 202637w ago 8-K Bullish 8/10 Entry $131.85 to $147.66 Now $92.21 −30.06% ▲ +11.99% +13.09% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers